Final SCCS Opinion on CBD

Final SCCS Opinion on CBD

Summary: On 24 April 2026, the SCCS concluded that pure CBD is safe for use in dermal and oral cosmetic products at concentrations up to 0.19%, with THC impurities permitted up to 0.00025%. Products that may result in inhalation exposure were not assessed. On 24 April...
Final SCCS Opinion on CBD

Final SCCS Opinion on Silver

Summary: On 24 April 2026, the SCCS issued its final opinion concluding that micron‑sized particulate silver is safe for use in cosmetic products, as it does not penetrate the skin. It is considered safe up to specified limits across product types, including...
Final SCCS Opinion on CBD

Final SCCS Opinion on BHA

Summary: The SCCS has finalized its safety opinion on butylated hydroxyanisole (BHA), concluding it is safe for use in leave-on and rinse-off cosmetics at concentrations up to 0.07%. This approval applies exclusively to dermal application and specifically excludes...
Final SCCS Opinion on CBD

Draft SCCS Opinion on Heliotropine

Summary: Substance: HeliotropineEffected Products: Fine fragrances for adultsDate of Implementation: TBC On 15 April 2026, the Scientific Committee on Consumer Safety (SCCS) published its draft opinion on the safety of Heliotropine in fine fragrances for...